These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 3355763
1. In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil. Peters GJ, van Dijk J, Laurensse E, van Groeningen CJ, Lankelma J, Leyva A, Nadal JC, Pinedo HM. Br J Cancer; 1988 Mar; 57(3):259-65. PubMed ID: 3355763 [Abstract] [Full Text] [Related]
2. Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma. Nadal JC, van Groeningen CJ, Pinedo HM, Peters GJ. Invest New Drugs; 1989 Jul; 7(2-3):163-72. PubMed ID: 2793368 [Abstract] [Full Text] [Related]
3. In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine. Peters GJ, Kraal I, Pinedo HM. Br J Cancer; 1992 Feb; 65(2):229-33. PubMed ID: 1739622 [Abstract] [Full Text] [Related]
4. Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin. Codacci-Pisanelli G, Noordhuis P, van der Wilt CL, Peters GJ. Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):733-9. PubMed ID: 18600533 [Abstract] [Full Text] [Related]
5. High-dose 5-Fluorouracil with uridine-diphosphoglucose rescue increases thymidylate synthase inhibition but not 5-Fluorouracil incorporation into RNA in murine tumors. Codacci-Pisanelli G, Van der Wilt CL, Smid K, Noordhuis P, Voorn D, Pinedo HM, Peters GJ. Oncology; 2002 Jun; 62(4):363-70. PubMed ID: 12138245 [Abstract] [Full Text] [Related]
6. Modulation of 5-fluorouracil in mice using uridine diphosphoglucose. Codacci-Pisanelli G, Kralovanszky J, van der Wilt CL, Noordhuis P, Colofiore JR, Martin DS, Franchi F, Peters GJ. Clin Cancer Res; 1997 Feb; 3(2):309-15. PubMed ID: 9815688 [Abstract] [Full Text] [Related]
7. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase. van der Wilt CL, Pinedo HM, Smid K, Cloos J, Noordhuis P, Peters GJ. Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671 [Abstract] [Full Text] [Related]
8. High-dose 5-fluorouracil with delayed uridine "rescue" in mice. Martin DS, Stolfi RL, Sawyer RC, Spiegelman S, Young CW. Cancer Res; 1982 Oct; 42(10):3964-70. PubMed ID: 7104997 [Abstract] [Full Text] [Related]
9. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma. Nadal JC, Van Groeningen CJ, Pinedo HM, Peters GJ. Biomed Pharmacother; 1988 Oct; 42(6):387-93. PubMed ID: 3064823 [Abstract] [Full Text] [Related]
10. Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouracil. Peters GJ, van der Wilt CL, Gyergyay F, van Laar JA, Treskes M, van der Vijgh WJ, Pinedo HM. Int J Radiat Oncol Biol Phys; 1992 Oct; 22(4):785-9. PubMed ID: 1312075 [Abstract] [Full Text] [Related]
11. Tissue-specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine. Darnowski JW, Handschumacher RE. Cancer Res; 1985 Nov; 45(11 Pt 1):5364-8. PubMed ID: 4053009 [Abstract] [Full Text] [Related]
12. Quantification of 5-fluorouracil incorporation into RNA of human and murine tumors as measured with a sensitive gas chromatography-mass spectrometry assay. Peters GJ, Noordhuis P, Komissarov A, Holwerda U, Kok M, Van Laar JA, Van der Wilt CL, Van Groeningen V, Pinedo HM. Anal Biochem; 1995 Oct 10; 231(1):157-63. PubMed ID: 8678295 [Abstract] [Full Text] [Related]
13. Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice. van der Wilt CL, van Laar JA, Gyergyay F, Smid K, Peters GJ. Eur J Cancer; 1992 Oct 10; 28A(12):2017-24. PubMed ID: 1329884 [Abstract] [Full Text] [Related]
14. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor. Al Safarjalani ON, Rais R, Shi J, Schinazi RF, Naguib FN, el Kouni MH. Cancer Chemother Pharmacol; 2006 Nov 10; 58(5):692-8. PubMed ID: 16528530 [Abstract] [Full Text] [Related]
15. Effect of WR-2721 on the toxicity and antitumor activity of the combination of carboplatin and 5-fluorouracil. van Laar JA, van der Wilt CL, Treskes M, van der Vijgh WJ, Peters GJ. Cancer Chemother Pharmacol; 1992 Nov 10; 31(2):97-102. PubMed ID: 1333372 [Abstract] [Full Text] [Related]
16. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells. Geoffroy FJ, Allegra CJ, Sinha B, Grem JL. Oncol Res; 1994 Nov 10; 6(12):581-91. PubMed ID: 7787251 [Abstract] [Full Text] [Related]
17. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors. Van der Wilt CL, Pinedo HM, Smid K, Peters GJ. Cancer Res; 1992 Sep 15; 52(18):4922-8. PubMed ID: 1516048 [Abstract] [Full Text] [Related]
18. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools. Pizzorno G, Wiegand RA, Lentz SK, Handschumacher RE. Cancer Res; 1992 Apr 01; 52(7):1660-5. PubMed ID: 1551097 [Abstract] [Full Text] [Related]
19. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines. Temmink OH, de Bruin M, Turksma AW, Cricca S, Laan AC, Peters GJ. Int J Biochem Cell Biol; 2007 Apr 01; 39(3):565-75. PubMed ID: 17098463 [Abstract] [Full Text] [Related]
20. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Peters GJ, Laurensse E, Leyva A, Lankelma J, Pinedo HM. Cancer Res; 1986 Jan 01; 46(1):20-8. PubMed ID: 2415245 [Abstract] [Full Text] [Related] Page: [Next] [New Search]